These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3384939

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. [Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
    Rezvan SP, Sidorenko SV, Budanov SV.
    Antibiot Khimioter; 1995 Apr; 40(4):25-9. PubMed ID: 7654095
    [Abstract] [Full Text] [Related]

  • 63. Phenomenon of resistance to Augmentin associated with sensitivity to ampicillin: occurrence and explanation.
    Brumfitt W, Hamilton-Miller JM, Dixson S, Gargan RA, Gooding A.
    J Clin Pathol; 1983 Jun; 36(6):670-3. PubMed ID: 6343436
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae.
    Simonet M, Moittie D, Philippon A, Descamps P, Veron M.
    J Antimicrob Chemother; 1989 May; 23(5):798-800. PubMed ID: 2547748
    [No Abstract] [Full Text] [Related]

  • 67. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
    Brown EM.
    J Antimicrob Chemother; 1984 Oct; 14(4):367-72. PubMed ID: 6501130
    [Abstract] [Full Text] [Related]

  • 68. Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations.
    Hill GB, Ayers OM, Everett BQ.
    J Antimicrob Chemother; 1991 Dec; 28(6):855-67. PubMed ID: 1816182
    [Abstract] [Full Text] [Related]

  • 69. [The effectiveness of so-called potentiated penicillins (augmentin and tazobactam) in vitro].
    Blahová J, Hupková M, Krcméry V.
    Cas Lek Cesk; 1995 Sep 06; 134(17):558-61. PubMed ID: 7553760
    [Abstract] [Full Text] [Related]

  • 70. In vitro susceptibility-resistance patterns of bacterial isolates from burn patients to augmentin and timentin.
    Holder IA, Vanderpool L, Wesselman J.
    J Burn Care Rehabil; 1985 Sep 06; 6(4):331-4. PubMed ID: 3879938
    [No Abstract] [Full Text] [Related]

  • 71. [A study on the disc sensitivity test for clavulanic acid/amoxicillin combination].
    Kanazawa Y, Kuramata T, Matsumoto K.
    Jpn J Antibiot; 1988 Sep 06; 41(9):1223-30. PubMed ID: 3241324
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.
    Wexler HM, Harris B, Carter WT, Finegold SM.
    Antimicrob Agents Chemother; 1985 May 06; 27(5):876-8. PubMed ID: 2990330
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. In vitro susceptibilities of Escherichia coli and Klebsiella spp. to ampicillin-sulbactam and amoxicillin-clavulanic acid.
    Kacmaz B, Sultan N.
    Jpn J Infect Dis; 2007 Jul 06; 60(4):227-9. PubMed ID: 17642541
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
    Clark RB, Bartelt MA, Chan EL, Dalton HP.
    J Antimicrob Chemother; 1992 Jan 06; 29(1):57-67. PubMed ID: 1737725
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.